Litcius/Paper detail

Venetoclax in combination with cytarabine with or without idarubicin in children with relapsed or refractory acute myeloid leukaemia: a phase 1, dose-escalation study

Seth E. Karol, Thomas Alexander, Amit Budhraja, Stanley Pounds, Kristin Canavera, Lei Wang, Joshua Wolf, Jeffery M. Klco, Paul E. Mead, Soumyasri Das Gupta, Su Y. Kim, Ahmed Hamed Salem, Tammy L. Palenski, Norman J. Lacayo, Ching‐Hon Pui, Joseph T. Opferman, Jeffrey E. Rubnitz

2020The Lancet Oncology162 citationsDOIOpen Access PDF

Topics & Concepts

IdarubicinCytarabineVenetoclaxRefractory (planetary science)MedicineMyeloid leukaemiaMyeloidOncologyInternal medicineMyeloid leukemiaLeukemiaPhysicsChronic lymphocytic leukemiaAstrobiologyAcute Myeloid Leukemia ResearchNeutropenia and Cancer InfectionsAcute Lymphoblastic Leukemia research